26-September-2018: According to a report by Grand View Research, Inc., the market is likely to reach USD 247 million by 2025. Bioresorbable coronary stents are extensively used for treating coronary heart diseases. A bioresorbable stent, also referred to naturally-dissolving stents manufactured with materials that may dissolve or gets absorbed in the body. These stents are available in variety of brands such as Absorb BVS, Absorb 2nd Generation, Magmaris, Magnitude, MeRes-100, and DESolve.
In January 2018, Elixir Medical Corporation introduced its new stent technology called DynamXTM at conference held in Denver. It is based on bioadaptive drug-eluting stent (BA-DES) platform. The DynamX composed of seventy-one microns thin cobalt-chromium DES that is covered with a biodegradable polymer covering which releases a Novolimus. The Novolimus is an anti-inflammatory and anti-proliferative that allows the vessel to continue arterial pulsatile motion as well as the Glagovian, an adaptive remodeling. These two conditions are vital to slowdown the development of disease. The thin biodegradable polymer covering is intended in such a way that it should get absorb in six months to restored adaptive remodeling and natural pulsatile motion of the artery.
Increasing lifestyle diseases and associated risk of growth in atherosclerosis-related cardiac events, rising elderly population prone to coronary diseases, increasing number of percutaneous coronary intervention (PCI) procedures, and popularity of minimally invasive procedures can propel the bioresorbable coronary stents market over the forecast period (2016 to 2025). In addition, growing focus of companies on clinical trials of bioresorbable stents and growing use of these stents by surgeons can have positive impact on the market.
Europe is the major contributor for the market due to availability of CE-approved stents and lack of auditing to check PCI procedure. Asia Pacific is likely to show rapid growth due to high growing coronary stenting procedures.
Key companies operating in the market include Meril Lifesciences Pvt. Ltd., Arterial Remodeling Technologies, Elixir Medical Corporation, Biotronik, and Abbott.
In-Depth Research Report On Bioresorbable Coronary Stents Market:
https://www.grandviewresearch.com/industry-analysis/bioresorbable-coronary-stents-market
No comments:
Post a Comment